examining the economic impacts of biosimilars in oncology
Published 5 months ago • 7 plays • Length 11:00Download video MP4
Download video MP3
Similar videos
-
6:01
economic impact of biosimilars in oncology
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:54
dr. kwa on the potential impact of biosimilars in oncology
-
1:07
impact of biosimilars on the field of oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
4:12
the basics of biosimilars
-
7:21
biologic drugs and biosimilars
-
1:00:26
"monoclonal antibody manufacturing: transforming our most important biologics manufacturing process"
-
6:07
manufacturing of biologics
-
0:32
the potential of biosimilars in cancer treatment
-
2:04
the impact of the fda's approval of the first 'biosimilar' drug
-
2:17
dr. kolberg explains the approval process for biosimilars
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
1:00
dr. kris on the impact of bevacizumab biosimilars in lung cancer
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
0:41
similarity of biosimilars and biologics
-
5:59
dr ali mcbride discusses the role of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
7:20
biosimilars in oncology: addressing awareness